LEADER 02128nam 2200553 450 001 9910787561603321 005 20230803030851.0 010 $a1-60805-175-7 035 $a(CKB)2670000000400500 035 $a(EBL)1310827 035 $a(OCoLC)854975263 035 $a(SSID)ssj0001169902 035 $a(PQKBManifestationID)11960264 035 $a(PQKBTitleCode)TC0001169902 035 $a(PQKBWorkID)11168382 035 $a(PQKB)10290500 035 $a(MiAaPQ)EBC1310827 035 $a(Au-PeEL)EBL1310827 035 $a(CaPaEBR)ebr10756234 035 $a(EXLCZ)992670000000400500 100 $a20111102d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTreatise on ocular drug delivery /$feditor, Ashim K. Mitra 210 1$aSharjah, United Arab Emirates ;$aOak Park, Illinois :$cBentham Science Publishers,$d[2013] 210 4$dİ2013 215 $a1 online resource (301 p.) 300 $aDescription based upon print version of record. 311 $a1-60805-347-4 320 $aIncludes bibliographical references and index. 327 $aCover; Title; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chapter 09; Chapter 10; INDEX 330 $aThis monograph covers a range of topics on ocular pharmacology, such as the biochemical background of specific eye diseases, challenges for ocular drug delivery, the role of influx and efflux transporters, novel drug delivery systems, pharmacokinetics, regulatory aspects, and patenting opportunities for researchers. 606 $aDrug delivery systems 606 $aEye$xDiseases$xTreatment 615 0$aDrug delivery systems. 615 0$aEye$xDiseases$xTreatment. 676 $a617.7 676 $a617.7061 701 $aMitra$b Ashim K.$f1954-$01517637 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910787561603321 996 $aTreatise on ocular drug delivery$93846541 997 $aUNINA LEADER 02806nam 2200553Ia 450 001 9910780312303321 005 20230617011033.0 010 $a1-280-17645-8 010 $a9786610176458 010 $a0-309-52989-1 035 $a(CKB)111090425020470 035 $a(EBL)3564034 035 $a(SSID)ssj0000106794 035 $a(PQKBManifestationID)11982218 035 $a(PQKBTitleCode)TC0000106794 035 $a(PQKBWorkID)10111087 035 $a(PQKB)11518395 035 $a(MiAaPQ)EBC3564034 035 $a(Au-PeEL)EBL3564034 035 $a(CaPaEBR)ebr10055002 035 $a(CaONFJC)MIL17645 035 $a(OCoLC)55636649 035 $a(EXLCZ)99111090425020470 100 $a20040414d2004 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAssessment of the Army plan for the Pine Bluff non-stockpile facility /$fCommittee on Review and Assessment of the Army Non-Stockpile Chemical Materiel Demilitarization Program: Pine Bluff, Board on Army Science and Technology, Division on Engineering and Physical Sciences, National Research Council of the National Academies 210 $aWashington, D.C. $cNational Academies Press$d2004 215 $a1 online resource (98 p.) 300 $a"This study was supported by Contract/Grant No. DAAD19-03-C-0046, between the National Academies of Sciences and the Department of the Army"--T.p. verso. 311 1 $a0-309-09138-1 320 $aIncludes bibliographcial references (p. 65-66). 327 $a""Front Matter""; ""Preface""; ""Acknowledgment of Reviewers""; ""Contents""; ""Figures and Tables""; ""Acronyms and Definitions""; ""Executive Summary""; ""1 Background and Overview""; ""2 The Pine Bluff Non-Stockpile Facility""; ""3 Worker Protection and Potential for Offsite Release""; ""4 Management of Process and Nonprocess Pine Bluff Non-Stockpile Facility Secondary Wastes""; ""5 Regulatory Approval and Permitting and Public Involvement""; ""6 A Greater Role for the Explosive Destruction System in Destruction of the Pine Bluff Inventory of Recovered Chemical Warfare Material"" 327 $a""References""""Appendixes""; ""Appendix A Committee Member Biographical Sketches""; ""Appendix B Committee Meetings and Other Activities""; ""Appendix C Analysis of the Pine Bluff Non-Stockpile Facility Schedule"" 606 $aChemical weapons disposal$zArkansas$zPine Bluff 606 $aMilitary engineering 615 0$aChemical weapons disposal 615 0$aMilitary engineering. 676 $a623.445 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910780312303321 996 $aAssessment of the Army plan for the Pine Bluff non-stockpile facility$93851079 997 $aUNINA